MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
347.90%
Quick Ratio
345.18%
Cash Ratio
234.87%
Debt to Asset Ratio
27.23%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Investments, long-term
    • Deferred tax asset
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Retained earnings
    • Trade payables
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
549,769
589,398
752,502
646,999
Investments, short-term
118,022
51,520
22,838
25,582
Trade receivables, net
110,995
108,222
96,787
100,651
Inventory, net
6,360
5,281
5,357
6,882
Prepaid expenses
19,311
16,801
16,014
23,308
Other current assets
9,877
7,595
13,516
35,378
Total current assets
814,334
778,817
907,014
838,800
Property and equipment, net
-
-
-
1,440
Investments, long-term
294,668
229,555
107,127
105,831
Intangible assets, net
77,496
83,457
89,418
95,380
Deferred tax asset
156,765
153,562
149,699
157,075
Other noncurrent assets
29,821
26,433
18,373
9,692
Total noncurrent assets
558,750
493,007
364,617
369,418
Total assets
1,373,084
1,271,824
1,271,631
1,208,218
Trade payables
21,684
28,600
17,693
26,341
Accrued compensation
12,091
6,726
18,443
14,935
Accrued expenses
169,128
150,107
191,039
161,302
Current portion of long-term debt
20,000
20,000
20,000
20,000
Other current liabilities
11,167
11,907
4,957
825
Total current liabilities
234,070
217,340
252,132
223,403
Long-term debt, net
133,961
138,814
143,663
148,506
Other noncurrent liabilities
5,810
5,321
5,618
1,186
Total noncurrent liabilities
139,771
144,135
149,281
149,692
Total liabilities
373,841
361,475
401,413
373,095
Common stock-0.00001 par value 500,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 58,120,695 and 57,726,170 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1
1
1
1
Additional paid in capital
731,147
717,370
708,968
696,348
Accumulated other comprehensive (loss) income
-727
-413
346
357
Retained earnings
268,822
193,391
160,903
138,417
Total stockholders' equity
999,243
910,349
870,218
835,123
Total liabilities and stockholders' equity
1,373,084
1,271,824
1,271,631
1,208,218
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$549,769K (0.68%↑ Y/Y)Investments, short-term$118,022K (513.93%↑ Y/Y)Trade receivables,net$110,995K (19.37%↑ Y/Y)Prepaid expenses$19,311K (5.16%↑ Y/Y)Other current assets$9,877K (14.37%↑ Y/Y)Inventory, net$6,360K (4.26%↑ Y/Y)Investments, long-term$294,668K (175.37%↑ Y/Y)Deferred tax asset$156,765K (-22.08%↓ Y/Y)Intangible assets, net$77,496K (-23.53%↓ Y/Y)Other noncurrentassets$29,821K (445.67%↑ Y/Y)Total current assets$814,334K (17.79%↑ Y/Y)Total noncurrentassets$558,750K (34.10%↑ Y/Y)Total assets$1,373,084K (23.92%↑ Y/Y)Total liabilities andstockholders' equity$1,373,084K (23.92%↑ Y/Y)Total stockholders'equity$999,243K (29.25%↑ Y/Y)Total liabilities$373,841K (11.62%↑ Y/Y)Accumulated othercomprehensive (loss) income-$727K (-404.18%↓ Y/Y)Additional paid in capital$731,147K (6.69%↑ Y/Y)Retained earnings$268,822K (207.04%↑ Y/Y)Total currentliabilities$234,070K (29.94%↑ Y/Y)Total noncurrentliabilities$139,771K (-9.70%↓ Y/Y)Common stock-0.00001par value...$1K (0.00%↑ Y/Y)Accrued expenses$169,128K (42.97%↑ Y/Y)Trade payables$21,684K (-23.38%↓ Y/Y)Current portion oflong-term debt$20,000K (6.67%↑ Y/Y)Accrued compensation$12,091K (3.03%↑ Y/Y)Other currentliabilities$11,167K (265.41%↑ Y/Y)Long-term debt, net$133,961K (-12.64%↓ Y/Y)Other noncurrentliabilities$5,810K (301.24%↑ Y/Y)

Harmony Biosciences Holdings, Inc. (HRMY)

Harmony Biosciences Holdings, Inc. (HRMY)